Antibodies to Self-Antigens Predispose to Primary Lung Allograft Dysfunction and Chronic Rejection

被引:103
|
作者
Bharat, Ankit
Saini, Deepti
Steward, Nancy
Hachem, Ramsey
Trulock, Elbert P.
Patterson, Alexander
Meyers, Bryan F.
Mohanakumar, Thalachallour [1 ]
机构
[1] Washington Univ, Sch Med, Dept Surg,Div Pulm Med, Div Cardiothorac Surg,Dept Internal Med, St Louis, MO 63110 USA
来源
ANNALS OF THORACIC SURGERY | 2010年 / 90卷 / 04期
关键词
BRONCHIOLITIS OBLITERANS SYNDROME; PRIMARY GRAFT DYSFUNCTION; V COLLAGEN; TRANSPLANTATION; IMMUNITY; INJURY; HLA;
D O I
10.1016/j.athoracsur.2010.06.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Primary graft dysfunction (PGD) is a known risk factor for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Here, we report that preformed antibodies to self-antigens increase PGD risk and promote BOS. Methods. Adult lung transplant recipients (n = 142) were included in the study. Primary graft dysfunction and BOS were diagnosed based on International Society for Heart and Lung Transplantation guidelines. Antibodies to self-antigens k-alpha-1 tubulin, collagen type V, and collagen I were quantitated using standardized enzyme-linked immunosorbent assays, and cytokines were analyzed using Luminex immunoassays (Biosource International, Camirillo, CA). Human leukocyte antigen (HLA) antibodies were measured using Flow-PRA (One Lambda, Canoga Park, CA). Results. Lung transplant recipients with pretransplant antibodies to self-antigens had increased risk of PGD (odds ratio 3.09, 95% confidence interval: 1.2 to 8.1, p = 0.02) compared with recipients without. Conversely, in patients with PGD, 34.7% were positive for pretransplant antibodieswhereas in the PGD negative group, only 14.6% had antibodies (p = 0.03). Antibody positive patients demonstrated high levels of proinflammatory cytokines interleukin (IL)-1 beta (2.1-fold increase), IL-2 (3.0), IL-12 (2.5), IL-15 (3.0), and chemokines interferon-inducible protein-10 (3.9) and monocyte chemotactic protein-1 (3.1; p < 0.01 for all). On 5-year follow-up, patients without antibodies showed greater freedom from development of HLA antibodies compared with patients who had antibodies (class I: 67% versus 38%, p = 0.001; class II: 71% versus 41%, p < 0.001). Patients with pretransplant antibodies were found to have an independent relative risk of 2.3 (95% confidence interval: 1.7 to 4.5, p = 0.009) for developing BOS. Conclusions. Presence of antibodies to self-antigens pretransplant increases the risk of PGD immediately after transplant period and BOS on long-term follow-up. Primary graft dysfunction is associated with an inflammatory cascade that augments the alloimmune (anti-HLA) response that predisposes to BOS. (Ann Thorac Surg 2010;90:1094-101) (c) 2010 by The Society of Thoracic Surgeons
引用
收藏
页码:1094 / 1100
页数:7
相关论文
共 50 条
  • [31] DE NOVO ANTIBODIES TO HLA AND SELF-ANTIGENS ARE ASSOCIATED WITH ANTIBODY MEDIATED REJECTION IN CARDIAC TRANSPLANT RECEPIENTS
    Ramachandran, S.
    Phelan, D.
    Ewald, G. A.
    Moazami, N.
    Mohanakumar, T.
    HUMAN IMMUNOLOGY, 2009, 70 : S63 - S63
  • [32] Rejection and function and chronic allograft dysfunction
    de Fijter, Johan W.
    KIDNEY INTERNATIONAL, 2010, 78 : S38 - S41
  • [33] Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction
    Kaza, Vaidehi
    Zhu, Chengsong
    Terada, Lance S.
    Wang, Li
    Torres, Fernando
    Bollineni, Srinivas
    Mohanka, Manish
    Banga, Amit
    Joerns, John
    Mohanakumar, T.
    Li, Quan-Zhen
    HUMAN IMMUNOLOGY, 2021, 82 (01) : 25 - 35
  • [34] Update on the immunological mechanisms of primary graft dysfunction and chronic lung allograft dysfunction
    Jeong, Jong Cheol
    Gelman, Andrew E.
    Chong, Anita S.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2024, 29 (06) : 412 - 419
  • [35] Chronic Lung Allograft Dysfunction
    William F. Parker
    Remzi Bag
    Current Pulmonology Reports, 2018, 7 (4) : 169 - 175
  • [36] Chronic Lung Allograft Dysfunction
    Parker, William F.
    Bag, Remzi
    CURRENT PULMONOLOGY REPORTS, 2018, 7 (04) : 169 - 175
  • [37] Chronic lung allograft dysfunction
    Kumar, Anupam
    Garcha, Puneet Singh
    INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 38 (SUPPL 2) : 318 - 325
  • [38] Chronic lung allograft dysfunction
    Anupam Kumar
    Puneet Singh Garcha
    Indian Journal of Thoracic and Cardiovascular Surgery, 2022, 38 : 318 - 325
  • [39] Chronic lung allograft dysfunction
    Masaaki Sato
    Current Respiratory Care Reports, 2014, 3 (3): : 71 - 78
  • [40] Chronic lung allograft dysfunction
    Sato, Masaaki
    CURRENT PULMONOLOGY REPORTS, 2014, 3 (03) : 71 - 78